General Information
Product name
Human IGFBP1 ELISA Kit
Icons in SDS
Company Information
company name
Biorbyt., Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@biorbyt.com
Section 2
SECTION 2: Hazards identification
Emergency overview:NOT EXPECTED TO PRODUCE SIGNIFICANT ADVERSE HEALTH EFFECTS WHEN THE RECOMMENDED INSTRUCTIONS FOR USE ARE FOLLOWED. No known significant effects or critical hazards. Avoid prolonged contact with eyes, skin and clothing.
Potential Acute Health Effects
Eyes: No known significant effects or critical hazards. Skin: No known significant effects or critical hazards. Inhalation: No known significant effects or critical hazards. Ingestion: No known significant effects or critical hazards.
Potential chronic health
effects Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards. No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards.
